Golden Throat Holdings Group Company Limited (6896.HK)
HKD 3.08
(-0.65%)
HKD 3.08
(-0.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 336.73 Million CNY | -7.32% |
| 2022 | 363.32 Million CNY | 70.62% |
| 2021 | 212.94 Million CNY | 53.41% |
| 2020 | 138.8 Million CNY | -34.67% |
| 2019 | 212.46 Million CNY | 32.29% |
| 2018 | 160.61 Million CNY | 119.41% |
| 2017 | 73.2 Million CNY | -55.2% |
| 2016 | 163.4 Million CNY | -11.79% |
| 2015 | 185.25 Million CNY | 19.73% |
| 2014 | 154.72 Million CNY | 87.9% |
| 2013 | 82.34 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | 182.86 Million CNY | 18.84% |
| 2023 FY | 336.73 Million CNY | -7.32% |
| 2023 Q2 | 153.87 Million CNY | -47.36% |
| 2022 Q4 | 292.33 Million CNY | 311.79% |
| 2022 FY | 363.32 Million CNY | 70.62% |
| 2022 Q2 | 70.99 Million CNY | -46.18% |
| 2021 Q4 | 131.89 Million CNY | 62.71% |
| 2021 Q2 | 81.05 Million CNY | -33.62% |
| 2021 FY | 212.94 Million CNY | 53.41% |
| 2020 Q2 | 16.7 Million CNY | -89.0% |
| 2020 FY | 138.8 Million CNY | -34.67% |
| 2020 Q4 | 122.1 Million CNY | 630.89% |
| 2019 FY | 212.46 Million CNY | 32.29% |
| 2019 Q4 | 151.87 Million CNY | 150.66% |
| 2019 Q2 | 60.59 Million CNY | -50.85% |
| 2018 Q4 | 123.27 Million CNY | 230.12% |
| 2018 FY | 160.61 Million CNY | 119.41% |
| 2018 Q2 | 37.34 Million CNY | -32.71% |
| 2017 Q4 | 55.49 Million CNY | 213.38% |
| 2017 FY | 73.2 Million CNY | -55.2% |
| 2017 Q2 | 17.7 Million CNY | -58.67% |
| 2016 Q4 | 42.84 Million CNY | -64.46% |
| 2016 Q2 | 120.55 Million CNY | 66.91% |
| 2016 FY | 163.4 Million CNY | -11.79% |
| 2015 Q4 | 72.22 Million CNY | -36.09% |
| 2015 Q2 | 113.02 Million CNY | 32.02% |
| 2015 FY | 185.25 Million CNY | 19.73% |
| 2014 Q2 | 69.11 Million CNY | 62.09% |
| 2014 Q4 | 85.61 Million CNY | 23.87% |
| 2014 FY | 154.72 Million CNY | 87.9% |
| 2013 Q4 | 42.63 Million CNY | 0.0% |
| 2013 FY | 82.34 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 143.01 Million HKD | -135.462% |
| Grand Pharmaceutical Group Limited | 2.66 Billion HKD | 87.357% |
| Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 4225.692% |
| Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -723.726% |
| Qianhai Health Holdings Limited | -52.18 Million HKD | 745.304% |
| Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -834.296% |
| Essex Bio-Technology Limited | 310.32 Million HKD | -8.51% |
| Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
| PuraPharm Corporation Limited | -66.04 Million HKD | 609.855% |
| SSY Group Limited | 1.63 Billion HKD | 79.453% |
| JBM (Healthcare) Limited | 174.2 Million HKD | -93.3% |
| Jacobson Pharma Corporation Limited | 333.12 Million HKD | -1.085% |
| China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 97.228% |